Current Edition

advanced cancers

Surge raises $26M to take anti-cancer extended-release hydrogel into the clinic

Surge Therapeutics has raised money to take its extended-release biodegradable hydrogel into the clinic, reeling in $26 million to test its belief that implanting the …

Continue Reading →
albumin

New Cancer Target Identified for Albumin Enabled Anti-Cancer Therapeutics

Aarhus University’s Interdisciplinary Nanoscience Center (iNANO) and Albumedix Ltd. (‘Albumedix’) have entered into a strategic research collaboration to evaluate the transport properties of albumin for …

Continue Reading →